Mark F. Berry, MD, Thomas A. Sporn, MD, Joseph O. Moore, MD, Thomas A

Slides:

Advertisements

Similar presentations

Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages

Advertisements

Primary Small Cell Carcinoma of the Esophagus Jima Lv, MD, Jun Liang, MD, Jinwan Wang, MD, Luhua Wang, MD, Jie He, MD, Zefen Xiao, MD, Weibo Yin, MD Journal.

Kazuma Nagata, MD, Reiko Kaji, MD, Keisuke Tomii, MD

Timothy L. Van Natta, MD, Mark D. Iannettoni, MD, MBA

Successful Osimertinib Rechallenge in a Patient with T790M-Mutant Non–Small Cell Lung Cancer after Osimertinib-Induced Interstitial Lung Disease Eisaku.

Chia-Lin Hsu, MD, Kuan-Yu Chen, MD, PhD Journal of Thoracic Oncology

Rash in a Patient Treated with Pemetrexed for Relapsed Non-small Cell Lung Cancer Isabelle Declercq, MD, Yolande Lievens, MD, PhD, Eric Verbeken, MD,

Avoidance of completion pneumonectomy by sparing the right middle lobe

Unilateral Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia and Multiple Carcinoids Treated with Surgical Resection Sheeba Irshad, Emma McLean,

Outcomes of Second-Line Chemotherapy in Patients with Relapsed Extensive Small Cell Lung Cancer Sandra Froeschl, MD, Garth Nicholas, MD, FRCPC, Victor.

Joachim Pfannschmidt, MD, Hans Hoffmann, MD, Hendrick Dienemann, MD

Zeynep Eroglu, MD, Jae Kim, MD, Sharon Wilczynski, MD, PhD, Warren A

NA Journal of Thoracic Oncology

Electronic Updates for JTO Readers

Hedgehog Signaling Pathway and Lung Cancer

Frank Detterbeck, MD Journal of Thoracic Oncology

Uniportal video-assisted thoracoscopic bronchial sleeve lobectomy: First report Diego Gonzalez-Rivas, MD, FECTS, Ricardo Fernandez, MD, Eva Fieira, MD,

Treatment Modalities for T1N0 Esophageal Cancers: A Comparative Analysis of Local Therapy Versus Surgical Resection Mark F. Berry, MD, Josiane Zeyer-Brunner,

Successful Treatment with Erlotinib after Gefitinib-Induced Severe Interstitial Lung Disease Masayuki Takeda, MD, PhD, Isamu Okamoto, MD, PhD, Chihiro.

Surgical Treatment of a Giant Symptomatic Cardiac Lipoma

Thymoma: A Population-Based Study of the Management and Outcomes for the Province of British Columbia Caroline Mariano, MD, Diana N. Ionescu, MD, Winson.

Vertebral Collapse Caused by Bone Metastasis

Effective Treatment with Icotinib in Primary Adenoid Cystic Carcinoma of the Lung with Liver Metastasis Zhengbo Song, MD, Wei Wu, MD, Yiping Zhang, MD

Tamas F. Molnar, Cengiz Gebitekin, Akif Turna

Jeffrey Bradley, MD, Issam El Naqa, PhD Journal of Thoracic Oncology

Effects of Chemotherapy on Survival of Elderly Patients with Small-Cell Lung Cancer: Analysis of the SEER-Medicare Database Laura C. Caprario, MD, MS,

Use of Amiodarone After Major Lung Resection

VATS Thymectomy with 3D Vision: A Chance to Further Improve the Outcomes of Thymus Minimally Invasive Surgery Federico Attene, MD, Fabrizio Scognamillo,

Massive Bronchogenic Cyst

A Lung Cancer Responding to Hormonal Therapy

Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response

Elizabeth Cathcart-Rake, MD, Ariel Lopez-Chavez, MD, MS

Steve R. Siegal, MD, John G. Hunter, MD, James P. Dolan, MD, MCR

Positron Emission Tomography 18F-Fluorodeoxyglucose Uptake and Prognosis in Patients with Surgically Treated, Stage I Non-small Cell Lung Cancer: A Systematic.

Jennifer L. Dallas, MD, Michael A. Jantz, MD, Judith L

Nasion Swelling as the Presenting Symptom of Lung Adenocarcinoma

The Feasibility of Adjuvant Carboplatin and Docetaxel in Patients with Curatively Resected Non-small Cell Lung Cancer Thomas E. Stinchcombe, MD, Harry.

Mirror Mirror on the Wall, Who Is the Fairest of Them All

A Systematic Review of Restaging After Induction Therapy for Stage IIIa Lung Cancer: Prediction of Pathologic Stage Sara de Cabanyes Candela, MD, Frank.

Giant Malignant Myxoid Fibrous Histiocytoma of the Chest Wall

Jennifer S. Temel, MD, William F. Pirl, MD, Christopher J

Adjuvant Chemotherapy Is Associated with Improved Survival after Esophagectomy without Induction Therapy for Node-Positive Adenocarcinoma Paul J. Speicher,

Lymphovascular Invasion in Non–Small-Cell Lung Cancer: Implications for Staging and Adjuvant Therapy Kristin A Higgins, MD, Junzo P Chino, MD, Neal Ready,

Clinical Relevance of Our Multimodality Prognostic Score

Pulmonary Metastasectomy in Breast Cancer

Nicholas W. Choong, MD, Robert S. Hellman, MD

T4 or MI? Journal of Thoracic Oncology Volume 6, Issue 3, (March 2011)

Two Generations of Light/Never-Smokers With Advanced Adenocarcinoma of the Lung with Durable Responses to Erlotinib Nathan A. Pennell, MD, PhD, Lihong.

Giant Desmoid Tumor of the Chest Wall

Large Bronchopleural Fistula After Surgical Resection: Secret to Success Isabelle Delanote, MD, Werner Budts, MD, PhD, Paul De Leyn, MD, PhD, Christophe.

Extended Resections for Thymic Malignancies

European Lung Cancer Conference (ELCC) 2016 Organisation

Recurrent Primary Synovial Sarcoma of the Chest Wall

Andreas Rimner, MD, Kenneth E. Rosenzweig, MD

Tetsuzo Tagawa, MD, Miyuki Takasu, MD, Teruyoshi Ishida, MD

Metastatic Lung Cancer to the Pancreas

Intrathoracic Desmoid Tumor: Brief Report and Review of Literature

Mediastinal Sarcoma with Deviated Tracheal Anatomy

Multifocal lung cancer within ground glass lesions: Are favorable outcomes consequent to surgical resection or inherent to the disease? Mara B. Antonoff,

Large clinical databases for the study of lung cancer: Making up for the failure of randomized trials Chi-Fu Jeffrey Yang, MD, Matthew G. Hartwig, MD,

David Garfield, MD Journal of Thoracic Oncology

Induction Therapy For Locally Advanced Thymoma

Thymic Small Cell Carcinoma Shows Marked Response to Amrubicin

A Review of First-Line Treatment for Small-cell Lung Cancer

Mark A. Socinski, MD Journal of Thoracic Oncology

Robert Comis, MD, The Passing of a “Lung Man”

Induction Chemoradiation Is Not Superior to Induction Chemotherapy Alone in Stage IIIA Lung Cancer Asad A. Shah, MD, Mark F. Berry, MD, Ching Tzao, MD,

Ana Luque, MD, Edurne Arriola, MD, PhD Journal of Thoracic Oncology

Reply to “Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non–Small Cell Lung Cancer: Methodological Issues” Boris Sepesi,

Kristin A. Higgins, MD, Junzo P. Chino, MD, Neal Ready, MD, Mark W

Presentation transcript:

Giant Thoracic Liposarcoma Treated with Induction Chemotherapy Followed by Surgical Resection Mark F. Berry, MD, Thomas A. Sporn, MD, Joseph O. Moore, MD, Thomas A. D’Amico, MD Journal of Thoracic Oncology Volume 4, Issue 6, Pages 768-769 (June 2009) DOI: 10.1097/JTO.0b013e31819e77ff Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 1 A, Pretreatment computed tomography scan. B, Resected liposarcoma. Journal of Thoracic Oncology 2009 4, 768-769DOI: (10.1097/JTO.0b013e31819e77ff) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 2 A, Pretreatment biopsy showing myxoid liposarcoma. B, Posttreatment histology showing sclerosis and minimal cellularity. Journal of Thoracic Oncology 2009 4, 768-769DOI: (10.1097/JTO.0b013e31819e77ff) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions

FIGURE 3 Postoperative scan showing no residual or recurrent disease. Journal of Thoracic Oncology 2009 4, 768-769DOI: (10.1097/JTO.0b013e31819e77ff) Copyright © 2009 International Association for the Study of Lung Cancer Terms and Conditions